Larvol Delta - Apotex-announces-expansion-of-licensing-agreement-with-Formosa-Pharmaceuticals-to-Mexico-for-commercialization-of-clobetasol-propionate-ophthalmic-suspension-for-the-treatment-of-inflammation-and-pain-following-ocular-surgery

clobetasol nanosuspension (APP13007) - Formosa Labs, AimMax Therap

https://finance.yahoo.com/news/apotex-announces-expansion-licensing-agreement-223000846.html

May 6, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next